Resources from the same session
1151MO - Pathological response is an independent factor of overall survival and disease-free survival after neoadjuvant durvalumab in resectable non-small cell lung cancer (NSCLC) in the IFCT-1601 IONESCO phase II trial
Presenter: Marie Wislez
Session: Mini oral session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
1732MO - Pembrolizumab and nintedanib for patients with advanced mesothelioma
Presenter: François-Xavier Danlos
Session: Mini oral session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
LBA43 - GEMSTONE-301: A randomized, double-blind, placebo-controlled, phase III study of sugemalimab in patients with unresectable stage III non-small cell lung cancer (NSCLC) who had not progressed after concurrent or sequential chemoradiotherapy (CRT)
Presenter: Yi-Long Wu
Session: Mini oral session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
1171MO - PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy
Presenter: Nicolas Girard
Session: Mini oral session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
LBA61 - Durvalumab ± tremelimumab + platinum-etoposide in first-line extensive-stage SCLC (ES-SCLC): 3-year overall survival update from the phase III CASPIAN study
Presenter: Luis Paz-Ares
Session: Mini oral session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
1172MO - Durvalumab consolidation in patients with stage III non-resecable NSCLC with driver genomic alterations
Presenter: Mariona Riudavets Melia
Session: Mini oral session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
Discussion 1151MO and 1732MO
Presenter: Michael Thomas
Session: Mini oral session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
Discussion LBA43 and 1171MO
Presenter: Lizza Hendriks
Session: Mini oral session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast